134 related articles for article (PubMed ID: 20217516)
1. Prevention of beta-cell destruction in autoimmune diabetes: current approaches and future prospects.
Sedimbi SK; Sanjeevi CB
Adv Exp Med Biol; 2010; 654():611-26. PubMed ID: 20217516
[TBL] [Abstract][Full Text] [Related]
2. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
Fändrich F; Ungefroren H
Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
[TBL] [Abstract][Full Text] [Related]
3. Acceleration of autoimmune diabetes in Rheb-congenic NOD mice with β-cell-specific mTORC1 activation.
Sasaki H; Yasuda H; Moriyama H; Nakamura A; Shimizu M; Arai T; Nagata M; Hara K; Yokono K
Biochem Biophys Res Commun; 2011 May; 408(2):306-11. PubMed ID: 21513702
[TBL] [Abstract][Full Text] [Related]
4. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.
Xia CQ; Peng R; Qiu Y; Annamalai M; Gordon D; Clare-Salzler MJ
Diabetes; 2007 Aug; 56(8):2116-23. PubMed ID: 17496235
[TBL] [Abstract][Full Text] [Related]
5. Beta Cell Therapies for Preventing Type 1 Diabetes: From Bench to Bedside.
Brawerman G; Thompson PJ
Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33339173
[TBL] [Abstract][Full Text] [Related]
6. Insulin-producing intestinal K cells protect nonobese diabetic mice from autoimmune diabetes.
Mojibian M; Lam AW; Fujita Y; Asadi A; Grassl GA; Dickie P; Tan R; Cheung AT; Kieffer TJ
Gastroenterology; 2014 Jul; 147(1):162-171.e6. PubMed ID: 24662331
[TBL] [Abstract][Full Text] [Related]
7. New Insights into Immunotherapy Strategies for Treating Autoimmune Diabetes.
Cabello-Olmo M; Araña M; Radichev I; Smith P; Huarte E; Barajas M
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561568
[TBL] [Abstract][Full Text] [Related]
8. Selective destruction of mouse islet beta cells by human T lymphocytes in a newly-established humanized type 1 diabetic model.
Zhao Y; Guo C; Hwang D; Lin B; Dingeldein M; Mihailescu D; Sam S; Sidhwani S; Zhang Y; Jain S; Skidgel RA; Prabhakar BS; Mazzone T; Holterman MJ
Biochem Biophys Res Commun; 2010 Sep; 399(4):629-36. PubMed ID: 20691153
[TBL] [Abstract][Full Text] [Related]
9. T-lymphocyte recognition of beta cells in type 1 diabetes: clinical perspectives.
Boitard C
Diabetes Metab; 2013 Dec; 39(6):459-66. PubMed ID: 24139825
[TBL] [Abstract][Full Text] [Related]
10. Immune Depletion in Combination with Allogeneic Islets Permanently Restores Tolerance to Self-Antigens in Diabetic NOD Mice.
Gagliani N; Jofra T; Posgai AL; Atkinson MA; Battaglia M
PLoS One; 2015; 10(11):e0142318. PubMed ID: 26580221
[TBL] [Abstract][Full Text] [Related]
11. Beyond the hormone: insulin as an autoimmune target in type 1 diabetes.
Brezar V; Carel JC; Boitard C; Mallone R
Endocr Rev; 2011 Oct; 32(5):623-69. PubMed ID: 21700723
[TBL] [Abstract][Full Text] [Related]
12. A Preclinical Consortium Approach for Assessing the Efficacy of Combined Anti-CD3 Plus IL-1 Blockade in Reversing New-Onset Autoimmune Diabetes in NOD Mice.
Gill RG; Pagni PP; Kupfer T; Wasserfall CH; Deng S; Posgai A; Manenkova Y; Bel Hani A; Straub L; Bernstein P; Atkinson MA; Herold KC; von Herrath M; Staeva T; Ehlers MR; Nepom GT
Diabetes; 2016 May; 65(5):1310-6. PubMed ID: 26718498
[TBL] [Abstract][Full Text] [Related]
13. B7-H4.Ig inhibits the development of type 1 diabetes by regulating Th17 cells in NOD mice.
Lee IF; Wang X; Hao J; Akhoundsadegh N; Chen L; Liu L; Langermann S; Ou D; Warnock GL
Cell Immunol; 2013 Mar; 282(1):1-8. PubMed ID: 23623902
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulation and regeneration of islet Beta cells by cytokines in autoimmune type 1 diabetes.
Singh B; Nikoopour E; Huszarik K; Elliott JF; Jevnikar AM
J Interferon Cytokine Res; 2011 Oct; 31(10):711-9. PubMed ID: 21851268
[TBL] [Abstract][Full Text] [Related]
15. Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice.
Koulmanda M; Bhasin M; Hoffman L; Fan Z; Qipo A; Shi H; Bonner-Weir S; Putheti P; Degauque N; Libermann TA; Auchincloss H; Flier JS; Strom TB
Proc Natl Acad Sci U S A; 2008 Oct; 105(42):16242-7. PubMed ID: 18852471
[TBL] [Abstract][Full Text] [Related]
16. Effects of autoimmunity and immune therapy on beta-cell turnover in type 1 diabetes.
Sherry NA; Kushner JA; Glandt M; Kitamura T; Brillantes AM; Herold KC
Diabetes; 2006 Dec; 55(12):3238-45. PubMed ID: 17130466
[TBL] [Abstract][Full Text] [Related]
17. Ectopic PDX-1 expression in liver ameliorates type 1 diabetes.
Shternhall-Ron K; Quintana FJ; Perl S; Meivar-Levy I; Barshack I; Cohen IR; Ferber S
J Autoimmun; 2007; 28(2-3):134-42. PubMed ID: 17383157
[TBL] [Abstract][Full Text] [Related]
18. Autoimmunity and beta cell regeneration in mouse and human type 1 diabetes: the peace is not enough.
Ablamunits V; Sherry NA; Kushner JA; Herold KC
Ann N Y Acad Sci; 2007 Apr; 1103():19-32. PubMed ID: 17376841
[TBL] [Abstract][Full Text] [Related]
19. B cell therapy is β-tested: Rituximab puts a pause on β-cell destruction.
Clynes R
Islets; 2010; 2(2):130-2. PubMed ID: 21099307
[No Abstract] [Full Text] [Related]
20. Prevention of autoimmune diabetes by immunogene therapy using recombinant vaccinia virus expressing glutamic acid decarboxylase.
Jun HS; Chung YH; Han J; Kim A; Yoo SS; Sherwin RS; Yoon JW
Diabetologia; 2002 May; 45(5):668-76. PubMed ID: 12107747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
